allicin has been researched along with Bladder Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XW; Dong, Z; He, CW; He, HJ; Huang, PP; Lin, LG; Liu, JJ; Liu, XG; Wang, J; Wu, P; Wu, XD | 1 |
| Cao, KY; Chen, XJ; Huang, XR; Mao, XP; Qiu, SP; Xu, L; Yuan, GQ | 1 |
2 other study(ies) available for allicin and Bladder Cancer
| Article | Year |
|---|---|
Synergic anti-tumour effect of B7.1 gene modified tumour vaccine combined with allicin for murine bladder tumour.
Topics: Animals; B7-1 Antigen; Cancer Vaccines; Combined Modality Therapy; Disulfides; Female; Genetic Therapy; Mice; Mice, Inbred C3H; Sulfinic Acids; T-Lymphocytes, Cytotoxic; Transfection; Urinary Bladder Neoplasms; Vaccination | 2005 |
[The effect of cell killing and apoptosis by human herpes simplex virus- thymidine kinase/ganciclovir system combined with allitride in BIU87 cells].
Topics: Apoptosis; Disulfides; Drug Synergism; Ganciclovir; Genetic Therapy; Herpesvirus 1, Human; Humans; In Vitro Techniques; Sulfinic Acids; Thymidine Kinase; Transfection; Urinary Bladder Neoplasms | 2005 |